カテゴリー： QYResearch, 世界

世界の血小板血症骨髄線維症治療市場 2019年

【英語タイトル】Global Thrombocythaemia Myelofibrosis Treatment Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X16548）・商品コード：DATA909X16548
・発行会社（調査会社）：QYResearch
・発行日：2019年11月22日（※2024年版があります。お問い合わせください）
・ページ数：101
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、血小板血症骨髄線維症治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、プラシノスタット、ルミネスピブ、シムツズマブ、INCB-39110、その他に、用途別には、クリニック、病院、その他にセグメント区分し、血小板血症骨髄線維症治療の世界市場を分析しました。


・エグゼクティブ・サマリー
・血小板血症骨髄線維症治療の世界市場概要
・血小板血症骨髄線維症治療の製造コスト構成分析
・血小板血症骨髄線維症治療の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・血小板血症骨髄線維症治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・血小板血症骨髄線維症治療のセグメント分析（種類別）
（プラシノスタット、ルミネスピブ、シムツズマブ、INCB-39110、その他）
・血小板血症骨髄線維症治療のセグメント分析（用途別）
（クリニック、病院、その他）
・血小板血症骨髄線維症治療の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Celgene Corporation、Gilead Sciences, Inc.、Incyte Corporation、JW Pharmaceutical Corporation、Nippon Shinyaku Co., Ltd.、Novartis AG、Pfizer Inc.、）
・血小板血症骨髄線維症治療の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Thrombocythaemia Myelofibrosis Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Thrombocythaemia Myelofibrosis Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Thrombocythaemia Myelofibrosis Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Thrombocythaemia Myelofibrosis Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Thrombocythaemia Myelofibrosis Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Celgene Corporation
Gilead Sciences, Inc.
Incyte Corporation
JW Pharmaceutical Corporation
Nippon Shinyaku Co., Ltd.
Novartis AG
Pfizer Inc.
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Pracinostat
Luminespib
Simtuzumab
INCB-39110
Others

Segment by Application
Clinic
Hospital
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Thrombocythaemia Myelofibrosis Treatment
1.1 Definition of Thrombocythaemia Myelofibrosis Treatment
1.2 Thrombocythaemia Myelofibrosis Treatment Segment by Type
1.2.1 Global Thrombocythaemia Myelofibrosis Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Pracinostat
1.2.3 Luminespib
1.2.4 Simtuzumab
1.2.5 INCB-39110
1.2.6 Others
1.3 Thrombocythaemia Myelofibrosis Treatment Segment by Applications
1.3.1 Global Thrombocythaemia Myelofibrosis Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Thrombocythaemia Myelofibrosis Treatment Overall Market
1.4.1 Global Thrombocythaemia Myelofibrosis Treatment Revenue (2014-2025)
1.4.2 Global Thrombocythaemia Myelofibrosis Treatment Production (2014-2025)
1.4.3 North America Thrombocythaemia Myelofibrosis Treatment Status and Prospect (2014-2025)
1.4.4 Europe Thrombocythaemia Myelofibrosis Treatment Status and Prospect (2014-2025)
1.4.5 China Thrombocythaemia Myelofibrosis Treatment Status and Prospect (2014-2025)
1.4.6 Japan Thrombocythaemia Myelofibrosis Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia Thrombocythaemia Myelofibrosis Treatment Status and Prospect (2014-2025)
1.4.8 India Thrombocythaemia Myelofibrosis Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Thrombocythaemia Myelofibrosis Treatment
2.3 Manufacturing Process Analysis of Thrombocythaemia Myelofibrosis Treatment
2.4 Industry Chain Structure of Thrombocythaemia Myelofibrosis Treatment

3 Development and Manufacturing Plants Analysis of Thrombocythaemia Myelofibrosis Treatment
3.1 Capacity and Commercial Production Date
3.2 Global Thrombocythaemia Myelofibrosis Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Thrombocythaemia Myelofibrosis Treatment
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Thrombocythaemia Myelofibrosis Treatment Production and Capacity Analysis
4.2 Thrombocythaemia Myelofibrosis Treatment Revenue Analysis
4.3 Thrombocythaemia Myelofibrosis Treatment Price Analysis
4.4 Market Concentration Degree

5 Thrombocythaemia Myelofibrosis Treatment Regional Market Analysis
5.1 Thrombocythaemia Myelofibrosis Treatment Production by Regions
5.1.1 Global Thrombocythaemia Myelofibrosis Treatment Production by Regions
5.1.2 Global Thrombocythaemia Myelofibrosis Treatment Revenue by Regions
5.2 Thrombocythaemia Myelofibrosis Treatment Consumption by Regions
5.3 North America Thrombocythaemia Myelofibrosis Treatment Market Analysis
5.3.1 North America Thrombocythaemia Myelofibrosis Treatment Production
5.3.2 North America Thrombocythaemia Myelofibrosis Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Thrombocythaemia Myelofibrosis Treatment Import and Export
5.4 Europe Thrombocythaemia Myelofibrosis Treatment Market Analysis
5.4.1 Europe Thrombocythaemia Myelofibrosis Treatment Production
5.4.2 Europe Thrombocythaemia Myelofibrosis Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Thrombocythaemia Myelofibrosis Treatment Import and Export
5.5 China Thrombocythaemia Myelofibrosis Treatment Market Analysis
5.5.1 China Thrombocythaemia Myelofibrosis Treatment Production
5.5.2 China Thrombocythaemia Myelofibrosis Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Thrombocythaemia Myelofibrosis Treatment Import and Export
5.6 Japan Thrombocythaemia Myelofibrosis Treatment Market Analysis
5.6.1 Japan Thrombocythaemia Myelofibrosis Treatment Production
5.6.2 Japan Thrombocythaemia Myelofibrosis Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Thrombocythaemia Myelofibrosis Treatment Import and Export
5.7 Southeast Asia Thrombocythaemia Myelofibrosis Treatment Market Analysis
5.7.1 Southeast Asia Thrombocythaemia Myelofibrosis Treatment Production
5.7.2 Southeast Asia Thrombocythaemia Myelofibrosis Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Thrombocythaemia Myelofibrosis Treatment Import and Export
5.8 India Thrombocythaemia Myelofibrosis Treatment Market Analysis
5.8.1 India Thrombocythaemia Myelofibrosis Treatment Production
5.8.2 India Thrombocythaemia Myelofibrosis Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Thrombocythaemia Myelofibrosis Treatment Import and Export

6 Thrombocythaemia Myelofibrosis Treatment Segment Market Analysis (by Type)
6.1 Global Thrombocythaemia Myelofibrosis Treatment Production by Type
6.2 Global Thrombocythaemia Myelofibrosis Treatment Revenue by Type
6.3 Thrombocythaemia Myelofibrosis Treatment Price by Type

7 Thrombocythaemia Myelofibrosis Treatment Segment Market Analysis (by Application)
7.1 Global Thrombocythaemia Myelofibrosis Treatment Consumption by Application
7.2 Global Thrombocythaemia Myelofibrosis Treatment Consumption Market Share by Application (2014-2019)

8 Thrombocythaemia Myelofibrosis Treatment Major Manufacturers Analysis
8.1 Celgene Corporation
8.1.1 Celgene Corporation Thrombocythaemia Myelofibrosis Treatment Production Sites and Area Served
8.1.2 Celgene Corporation Product Introduction, Application and Specification
8.1.3 Celgene Corporation Thrombocythaemia Myelofibrosis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Gilead Sciences, Inc.
8.2.1 Gilead Sciences, Inc. Thrombocythaemia Myelofibrosis Treatment Production Sites and Area Served
8.2.2 Gilead Sciences, Inc. Product Introduction, Application and Specification
8.2.3 Gilead Sciences, Inc. Thrombocythaemia Myelofibrosis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Incyte Corporation
8.3.1 Incyte Corporation Thrombocythaemia Myelofibrosis Treatment Production Sites and Area Served
8.3.2 Incyte Corporation Product Introduction, Application and Specification
8.3.3 Incyte Corporation Thrombocythaemia Myelofibrosis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 JW Pharmaceutical Corporation
8.4.1 JW Pharmaceutical Corporation Thrombocythaemia Myelofibrosis Treatment Production Sites and Area Served
8.4.2 JW Pharmaceutical Corporation Product Introduction, Application and Specification
8.4.3 JW Pharmaceutical Corporation Thrombocythaemia Myelofibrosis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Nippon Shinyaku Co., Ltd.
8.5.1 Nippon Shinyaku Co., Ltd. Thrombocythaemia Myelofibrosis Treatment Production Sites and Area Served
8.5.2 Nippon Shinyaku Co., Ltd. Product Introduction, Application and Specification
8.5.3 Nippon Shinyaku Co., Ltd. Thrombocythaemia Myelofibrosis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Novartis AG
8.6.1 Novartis AG Thrombocythaemia Myelofibrosis Treatment Production Sites and Area Served
8.6.2 Novartis AG Product Introduction, Application and Specification
8.6.3 Novartis AG Thrombocythaemia Myelofibrosis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Pfizer Inc.
8.7.1 Pfizer Inc. Thrombocythaemia Myelofibrosis Treatment Production Sites and Area Served
8.7.2 Pfizer Inc. Product Introduction, Application and Specification
8.7.3 Pfizer Inc. Thrombocythaemia Myelofibrosis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served

9 Development Trend of Analysis of Thrombocythaemia Myelofibrosis Treatment Market
9.1 Global Thrombocythaemia Myelofibrosis Treatment Market Trend Analysis
9.1.1 Global Thrombocythaemia Myelofibrosis Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 Thrombocythaemia Myelofibrosis Treatment Regional Market Trend
9.2.1 North America Thrombocythaemia Myelofibrosis Treatment Forecast 2019-2025
9.2.2 Europe Thrombocythaemia Myelofibrosis Treatment Forecast 2019-2025
9.2.3 China Thrombocythaemia Myelofibrosis Treatment Forecast 2019-2025
9.2.4 Japan Thrombocythaemia Myelofibrosis Treatment Forecast 2019-2025
9.2.5 Southeast Asia Thrombocythaemia Myelofibrosis Treatment Forecast 2019-2025
9.2.6 India Thrombocythaemia Myelofibrosis Treatment Forecast 2019-2025
9.3 Thrombocythaemia Myelofibrosis Treatment Market Trend (Product Type)
9.4 Thrombocythaemia Myelofibrosis Treatment Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Thrombocythaemia Myelofibrosis Treatment Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Thrombocythaemia Myelofibrosis Treatment
Table Global Thrombocythaemia Myelofibrosis Treatment Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Thrombocythaemia Myelofibrosis Treatment Production Market Share by Types in 2018
Figure Pracinostat Product Picture
Figure Luminespib Product Picture
Figure Simtuzumab Product Picture
Figure INCB-39110 Product Picture
Figure Others Product Picture
Table Global Thrombocythaemia Myelofibrosis Treatment Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Thrombocythaemia Myelofibrosis Treatment Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Others
Figure Global Thrombocythaemia Myelofibrosis Treatment Revenue (Million USD) (2014-2025)
Figure Global Thrombocythaemia Myelofibrosis Treatment Production (K Pcs) (2014-2025)
Figure North America Thrombocythaemia Myelofibrosis Treatment Market Size (Million USD) (2014-2025)
Figure Europe Thrombocythaemia Myelofibrosis Treatment Market Size (Million USD) (2014-2025)
Figure China Thrombocythaemia Myelofibrosis Treatment Market Size (Million USD) (2014-2025)
Figure Japan Thrombocythaemia Myelofibrosis Treatment Market Size (Million USD) (2014-2025)
Figure Southeast Asia Thrombocythaemia Myelofibrosis Treatment Market Size (Million USD) (2014-2025)
Figure India Thrombocythaemia Myelofibrosis Treatment Market Size (Million USD) (2014-2025)
Table Thrombocythaemia Myelofibrosis Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Thrombocythaemia Myelofibrosis Treatment in 2018
Figure Manufacturing Process Analysis of Thrombocythaemia Myelofibrosis Treatment
Figure Industry Chain Structure of Thrombocythaemia Myelofibrosis Treatment
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Thrombocythaemia Myelofibrosis Treatment Manufacturing Plants Distribution
Table Thrombocythaemia Myelofibrosis Treatment Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Thrombocythaemia Myelofibrosis Treatment Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Thrombocythaemia Myelofibrosis Treatment Production (K Pcs) of Major Manufacturers (2014-2019)
Table Thrombocythaemia Myelofibrosis Treatment Production Market Share of Major Manufacturers (2014-2019)
Figure Thrombocythaemia Myelofibrosis Treatment Production Share by Manufacturers in 2018
Table Thrombocythaemia Myelofibrosis Treatment Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Thrombocythaemia Myelofibrosis Treatment Revenue Market Share of Major Manufacturers (2014-2019)
Figure Thrombocythaemia Myelofibrosis Treatment Revenue Share by Manufacturers in 2018
Table Thrombocythaemia Myelofibrosis Treatment Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Thrombocythaemia Myelofibrosis Treatment Production by Regions 2014-2019 (K Pcs)
Table Global Thrombocythaemia Myelofibrosis Treatment Production Market Share by Regions 2014-2019
Figure Global Thrombocythaemia Myelofibrosis Treatment Production Market Share by Regions in 2018
Table Global Thrombocythaemia Myelofibrosis Treatment Revenue by Regions 2014-2019 (Million USD)
Table Global Thrombocythaemia Myelofibrosis Treatment Revenue Market Share by Regions 2014-2019
Figure Global Thrombocythaemia Myelofibrosis Treatment Revenue Market Share by Regions in 2018
Table Global Thrombocythaemia Myelofibrosis Treatment Consumption by Regions 2014-2019 (K Pcs)
Table Global Thrombocythaemia Myelofibrosis Treatment Consumption Market Share by Regions 2014-2019
Figure North America Thrombocythaemia Myelofibrosis Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure North America Thrombocythaemia Myelofibrosis Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table North America Thrombocythaemia Myelofibrosis Treatment Production, Consumption Import and Export (K Pcs)
Figure Europe Thrombocythaemia Myelofibrosis Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Thrombocythaemia Myelofibrosis Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Thrombocythaemia Myelofibrosis Treatment Production, Consumption Import and Export (K Pcs)
Figure China Thrombocythaemia Myelofibrosis Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure China Thrombocythaemia Myelofibrosis Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table China Thrombocythaemia Myelofibrosis Treatment Production, Consumption Import and Export (K Pcs)
Figure Japan Thrombocythaemia Myelofibrosis Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Thrombocythaemia Myelofibrosis Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Thrombocythaemia Myelofibrosis Treatment Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Thrombocythaemia Myelofibrosis Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Thrombocythaemia Myelofibrosis Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Thrombocythaemia Myelofibrosis Treatment Production, Consumption Import and Export (K Pcs)
Figure India Thrombocythaemia Myelofibrosis Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure India Thrombocythaemia Myelofibrosis Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table India Thrombocythaemia Myelofibrosis Treatment Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Thrombocythaemia Myelofibrosis Treatment Market Share by Application (2014-2019)
Figure Global Value (Consumption) Thrombocythaemia Myelofibrosis Treatment Market Share by Application (2014-2019)
Table Celgene Corporation Thrombocythaemia Myelofibrosis Treatment Production Sites and Area Served
Table Celgene Corporation Thrombocythaemia Myelofibrosis Treatment Product Introduction, Application and Specification
Table Celgene Corporation Thrombocythaemia Myelofibrosis Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Celgene Corporation Thrombocythaemia Myelofibrosis Treatment Production Growth Rate (2014-2019)
Table Celgene Corporation Thrombocythaemia Myelofibrosis Treatment Production Market Share (2014-2019)
Figure Celgene Corporation Thrombocythaemia Myelofibrosis Treatment Revenue Market Share (2014-2019)
Table Celgene Corporation Thrombocythaemia Myelofibrosis Treatment Main Business and Markets Served
Table Gilead Sciences, Inc. Thrombocythaemia Myelofibrosis Treatment Production Sites and Area Served
Table Gilead Sciences, Inc. Thrombocythaemia Myelofibrosis Treatment Product Introduction, Application and Specification
Table Gilead Sciences, Inc. Thrombocythaemia Myelofibrosis Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Gilead Sciences, Inc. Thrombocythaemia Myelofibrosis Treatment Production Growth Rate (2014-2019)
Table Gilead Sciences, Inc. Thrombocythaemia Myelofibrosis Treatment Production Market Share (2014-2019)
Figure Gilead Sciences, Inc. Thrombocythaemia Myelofibrosis Treatment Revenue Market Share (2014-2019)
Table Gilead Sciences, Inc. Thrombocythaemia Myelofibrosis Treatment Main Business and Markets Served
Table Incyte Corporation Thrombocythaemia Myelofibrosis Treatment Production Sites and Area Served
Table Incyte Corporation Thrombocythaemia Myelofibrosis Treatment Product Introduction, Application and Specification
Table Incyte Corporation Thrombocythaemia Myelofibrosis Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Incyte Corporation Thrombocythaemia Myelofibrosis Treatment Production Growth Rate (2014-2019)
Table Incyte Corporation Thrombocythaemia Myelofibrosis Treatment Production Market Share (2014-2019)
Figure Incyte Corporation Thrombocythaemia Myelofibrosis Treatment Revenue Market Share (2014-2019)
Table Incyte Corporation Thrombocythaemia Myelofibrosis Treatment Main Business and Markets Served
Table JW Pharmaceutical Corporation Thrombocythaemia Myelofibrosis Treatment Production Sites and Area Served
Table JW Pharmaceutical Corporation Thrombocythaemia Myelofibrosis Treatment Product Introduction, Application and Specification
Table JW Pharmaceutical Corporation Thrombocythaemia Myelofibrosis Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table JW Pharmaceutical Corporation Thrombocythaemia Myelofibrosis Treatment Production Growth Rate (2014-2019)
Table JW Pharmaceutical Corporation Thrombocythaemia Myelofibrosis Treatment Production Market Share (2014-2019)
Figure JW Pharmaceutical Corporation Thrombocythaemia Myelofibrosis Treatment Revenue Market Share (2014-2019)
Table JW Pharmaceutical Corporation Thrombocythaemia Myelofibrosis Treatment Main Business and Markets Served
Table Nippon Shinyaku Co., Ltd. Thrombocythaemia Myelofibrosis Treatment Production Sites and Area Served
Table Nippon Shinyaku Co., Ltd. Thrombocythaemia Myelofibrosis Treatment Product Introduction, Application and Specification
Table Nippon Shinyaku Co., Ltd. Thrombocythaemia Myelofibrosis Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Nippon Shinyaku Co., Ltd. Thrombocythaemia Myelofibrosis Treatment Production Growth Rate (2014-2019)
Table Nippon Shinyaku Co., Ltd. Thrombocythaemia Myelofibrosis Treatment Production Market Share (2014-2019)
Figure Nippon Shinyaku Co., Ltd. Thrombocythaemia Myelofibrosis Treatment Revenue Market Share (2014-2019)
Table Nippon Shinyaku Co., Ltd. Thrombocythaemia Myelofibrosis Treatment Main Business and Markets Served
Table Novartis AG Thrombocythaemia Myelofibrosis Treatment Production Sites and Area Served
Table Novartis AG Thrombocythaemia Myelofibrosis Treatment Product Introduction, Application and Specification
Table Novartis AG Thrombocythaemia Myelofibrosis Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis AG Thrombocythaemia Myelofibrosis Treatment Production Growth Rate (2014-2019)
Table Novartis AG Thrombocythaemia Myelofibrosis Treatment Production Market Share (2014-2019)
Figure Novartis AG Thrombocythaemia Myelofibrosis Treatment Revenue Market Share (2014-2019)
Table Novartis AG Thrombocythaemia Myelofibrosis Treatment Main Business and Markets Served
Table Pfizer Inc. Thrombocythaemia Myelofibrosis Treatment Production Sites and Area Served
Table Pfizer Inc. Thrombocythaemia Myelofibrosis Treatment Product Introduction, Application and Specification
Table Pfizer Inc. Thrombocythaemia Myelofibrosis Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Pfizer Inc. Thrombocythaemia Myelofibrosis Treatment Production Growth Rate (2014-2019)
Table Pfizer Inc. Thrombocythaemia Myelofibrosis Treatment Production Market Share (2014-2019)
Figure Pfizer Inc. Thrombocythaemia Myelofibrosis Treatment Revenue Market Share (2014-2019)
Table Pfizer Inc. Thrombocythaemia Myelofibrosis Treatment Main Business and Markets Served
Figure Global Thrombocythaemia Myelofibrosis Treatment Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Thrombocythaemia Myelofibrosis Treatment Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Thrombocythaemia Myelofibrosis Treatment Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Thrombocythaemia Myelofibrosis Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Thrombocythaemia Myelofibrosis Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Thrombocythaemia Myelofibrosis Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Thrombocythaemia Myelofibrosis Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Thrombocythaemia Myelofibrosis Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Thrombocythaemia Myelofibrosis Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Thrombocythaemia Myelofibrosis Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Thrombocythaemia Myelofibrosis Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Thrombocythaemia Myelofibrosis Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Thrombocythaemia Myelofibrosis Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Thrombocythaemia Myelofibrosis Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Thrombocythaemia Myelofibrosis Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Thrombocythaemia Myelofibrosis Treatment by Type (2019-2025)
Table Global Consumption (K Pcs) of Thrombocythaemia Myelofibrosis Treatment by Application (2019-2025)
Table Thrombocythaemia Myelofibrosis Treatment Distributors List
Table Thrombocythaemia Myelofibrosis Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Celgene Corporation、Gilead Sciences, Inc.、Incyte Corporation、JW Pharmaceutical Corporation、Nippon Shinyaku Co., Ltd.、Novartis AG、Pfizer Inc.、

★調査レポート[世界の血小板血症骨髄線維症治療市場 2019年] (コード：DATA909X16548)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の血小板血症骨髄線維症治療市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の出血性ショック治療市場 2019年
    DATA909X08944 / QYResearch / 2019年11月20日 / ※本調査レポートは、出血性ショック治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、YW-356、NVX-408、ニュートロライド、LB-1148、その他に、用途別には、病院、診療所、その他にセグメント区分し、出血性ショック治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・出血性ショック治療の世界市場概要 ・出血性ショック治療の製造コスト構成分析 ・出血性ショック治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・出血性ショック治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・出血性ショック治療のセグメント分析（種類別） （YW-356、NVX-408、ニュートロライド、LB-1148、その他）...The global Hemorrhagic Shock Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hemorrhagic Shock Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hemorrhagic Shock Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hemorrhagic Shock Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の水処理技術市場 2019年
    DATA909X17641 / QYResearch / 2019年11月22日 / ※本調査レポートは、水処理技術の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、逆浸透、限外ろ過、精密ろ過、電気透析、ガス分離に、用途別には、電力、エネルギー、建設、農業、化学、鉱業、鉱物、都市、その他にセグメント区分し、水処理技術の世界市場を分析しました。 ・エグゼクティブ・サマリー ・水処理技術の世界市場概要 ・水処理技術の製造コスト構成分析 ・水処理技術の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・水処理技術の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・水処理技術のセグメント分析（種類別） （逆浸透、限外ろ過、精密ろ過、電気透析、ガス分離）...The global Water Treatment Technology market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Water Treatment Technology volume and value at global level, regional level and company level. From a global perspective, this report represents overall Water Treatment Technology market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Water Treatment Technology in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の天然ガス処理市場 2019年
    DATA909X11869 / QYResearch / 2019年11月20日 / ※本調査レポートは、天然ガス処理の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、脱硫、脱炭に、用途別には、オンショア、オフショアにセグメント区分し、天然ガス処理の世界市場を分析しました。 ・エグゼクティブ・サマリー ・天然ガス処理の世界市場概要 ・天然ガス処理の製造コスト構成分析 ・天然ガス処理の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・天然ガス処理の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・天然ガス処理のセグメント分析（種類別） （脱硫、脱炭）...The global Natural Gas Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Natural Gas Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Natural Gas Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Natural Gas Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のディーゼル排気処理製品市場 2019年
    DATA909X06447 / QYResearch / 2019年11月15日 / ※本調査レポートは、ディーゼル排気処理製品の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、SCR触媒、DEFタンク、DEFインジェクター、DEF供給モジュール、DEFセンサー、NOxセンサーに、用途別には、乗用車、LCV、HCVにセグメント区分し、ディーゼル排気処理製品の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ディーゼル排気処理製品の世界市場概要 ・ディーゼル排気処理製品の製造コスト構成分析 ・ディーゼル排気処理製品の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ディーゼル排気処理製品の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ディーゼル排気処理製品のセグメント分析（種類別） （SCR触媒、DEFタンク、DEFインジェクター、DEF供給モジュール、DEFセンサー、NOxセンサー）...The global Diesel Exhaust Treatment Product market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Diesel Exhaust Treatment Product volume and value at global level, regional level and company level. From a global perspective, this report represents overall Diesel Exhaust Treatment Product market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Diesel Exhaust Treatment Product in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の廃水＆水処理装置市場 2019年
    DATA909X17590 / QYResearch / 2019年11月22日 / ※本調査レポートは、廃水＆水処理装置の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、媒体ろ過装置、膜ろ過装置に、用途別には、都市用、工業用にセグメント区分し、廃水＆水処理装置の世界市場を分析しました。 ・エグゼクティブ・サマリー ・廃水＆水処理装置の世界市場概要 ・廃水＆水処理装置の製造コスト構成分析 ・廃水＆水処理装置の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・廃水＆水処理装置の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・廃水＆水処理装置のセグメント分析（種類別） （媒体ろ過装置、膜ろ過装置）...The global Wastewater & Water Treatment Equipment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Wastewater & Water Treatment Equipment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Wastewater & Water Treatment Equipment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Wastewater & Water Treatment Equipment in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の強迫性障害治療市場 2019年
    DATA909X12150 / QYResearch / 2019年11月20日 / ※本調査レポートは、強迫性障害治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ADX-88178、ビトペルチン、CR-5542、分散剤IR、マレイン酸フルボキサミン、マヴォグルラント、その他に、用途別には、クリニック、病院、研究センターにセグメント区分し、強迫性障害治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・強迫性障害治療の世界市場概要 ・強迫性障害治療の製造コスト構成分析 ・強迫性障害治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・強迫性障害治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・強迫性障害治療のセグメント分析（種類別） （ADX-88178、ビトペルチン、CR-5542、分散剤IR、マレイン酸フルボキサミン、マヴォグルラント、その他）...The global Obsessive-Compulsive Disorder Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Obsessive-Compulsive Disorder Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Obsessive-Compulsive Disorder Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Obsessive-Compulsive Disorder Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の排水処理薬品市場 2019年
    DATA909X17588 / QYResearch / 2019年11月22日 / ※本調査レポートは、排水処理薬品の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、腐食防止剤＆スケール防止剤、凝固剤＆凝集剤、殺生物剤＆消毒剤、PH調整剤、その他に、用途別には、発電、石油＆ガス、都市用水処理、工業用水処理、その他にセグメント区分し、排水処理薬品の世界市場を分析しました。 ・エグゼクティブ・サマリー ・排水処理薬品の世界市場概要 ・排水処理薬品の製造コスト構成分析 ・排水処理薬品の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・排水処理薬品の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・排水処理薬品のセグメント分析（種類別） （腐食防止剤＆スケール防止剤、凝固剤＆凝集剤、殺生物剤＆消毒剤、PH調整剤、その他）...The global Waste Water Treatment Chemicals market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Waste Water Treatment Chemicals volume and value at global level, regional level and company level. From a global perspective, this report represents overall Waste Water Treatment Chemicals market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Waste Water Treatment Chemicals in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

    • ◆H&Iグローバルリサーチのお客様（例）◆